Procalcitonin Protocol Use to Guide Antibiotic Therapy Duration in the Intensive Care Unit

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

208 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-29

Study Completion Date

2024-11-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare and contrast antibiotic use and its effects on patient outcomes before and after the implementation of a PCT protocol in the ICU at Methodist Richardson Medical Center (MRMC).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Procalcitonin to Shorten Antibiotics Duration in ICU Patients

NCT01379547

Sepsis

UNKNOWN PHASE3

Procalcitonin Guided Versus Conventional Antibiotic Therapy in Patients With Sepsis in the ICU

NCT00987818

Sepsis Intensive Care

WITHDRAWN NA

PCT and Clinical Algorithm for Determination of Duration of Antibiotics

NCT01572831

Infection

COMPLETED PHASE3

Safety and Efficacy of Procalcitonin Guided Antibiotic Therapy in Adult Intensive Care Units (ICU's)

NCT01139489

Sepsis Severe Sepsis Septic Shock

COMPLETED NA

Procalcitonin to Guide Antibiotic Stop in Neurocritical Care Patients.

NCT03683693

Sepsis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Based on previous clinical trials, current literature supports the use of PCT levels in combination with clinical assessments to help determine optimal antibiotic therapy. On May 30, 2022, MRMC launched a PCT protocol in the ICU that allows clinical pharmacy specialists to order PCT levels in certain bacterial infections. In order to determine the effects of the protocol, a retrospective quasi-experimental review will be conducted

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Comparing Antibiotic Duration of Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

compare antibiotic duration of therapy

To compare antibiotic duration of therapy before and after the implementation of the PCT protocol in the ICU.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ● Patients aged 18 years or older

* Patients being monitored on the PCT protocol
* ICU location status for at least part of the admission
* Received antibiotics in the ICU for a diagnosis of:

* Community-acquired pneumonia
* Hospital-acquired pneumonia
* Ventilator-associated pneumonia
* Sepsis and/or septic shock
* Uncomplicated bacteremia with known source
* Chronic obstructive pulmonary disorder exacerbation
* Asthma exacerbation

Exclusion Criteria

* Received antibiotics in the ICU for a diagnosis of:

* Uncomplicated skin and soft tissue infections
* Abscess
* Empyema
* Bacterial infections that require prolonged antibiotic therapy (e.g., osteomyelitis, endocarditis, tuberculosis, etc.)
* Intra-abdominal infection
* Urinary tract infection
* Bacterial meningitis

* Estimated Glomerular Filtration Rate \<15 mL/min
* Requiring renal replacement therapy
* Status post cardiac arrest/target temperature management

Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes